1. Home
  2. AQMS vs MBAI Comparison

AQMS vs MBAI Comparison

Compare AQMS & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aqua Metals Inc.

AQMS

Aqua Metals Inc.

HOLD

Current Price

$4.03

Market Cap

12.8M

Sector

Industrials

ML Signal

HOLD

Logo Check-Cap Ltd. Ordinary Share

MBAI

Check-Cap Ltd. Ordinary Share

N/A

Current Price

$1.72

Market Cap

12.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AQMS
MBAI
Founded
2014
2004
Country
United States
Israel
Employees
N/A
85
Industry
Metal Fabrications
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
12.8M
12.0M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
AQMS
MBAI
Price
$4.03
$1.72
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
32.6K
86.5K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,100,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$600.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$1.31
52 Week High
$39.37
$3.92

Technical Indicators

Market Signals
Indicator
AQMS
MBAI
Relative Strength Index (RSI) 46.13 50.19
Support Level $4.01 $1.38
Resistance Level $4.47 $1.89
Average True Range (ATR) 0.29 0.19
MACD 0.04 0.01
Stochastic Oscillator 56.52 31.69

Price Performance

Historical Comparison
AQMS
MBAI

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

About MBAI Check-Cap Ltd. Ordinary Share

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: